Characteristic | Overall | CVD | |
---|---|---|---|
N = 9,082 | No 7,909(87.08%) | Yes 1,173(12.92%) | |
Age at HIV diagnosis (years) | Â | Â | Â |
 18–29 | 4,009 (44.14) | 3,778 (47.77) | 231 (19.69) |
 30–39 | 1,987 (21.88) | 1,772 (22.4) | 215 (18.33) |
 40–49 | 1,759 (19.37) | 1,388 (17.55) | 371 (31.63) |
 50–59 | 1,017 (11.2) | 767 (9.7) | 250 (21.31) |
 >=60 | 310 (3.41) | 204 (2.58) | 106 (9.04) |
Sex | Â | Â | Â |
 Female | 2,060 (22.68) | 1,694 (21.42) | 366 (31.2) |
 Male | 7,022 (77.32) | 6,215 (78.58) | 807 (68.8) |
Race | Â | Â | Â |
 White | 2,004 (22.07) | 1,756 (22.2) | 248 (21.14) |
 Black | 6,270 (69.04) | 5,402 (68.3) | 868 (74) |
 Hispanic and Other | 808 (8.9) | 751 (9.5) | 57 (4.86) |
Residence | Â | Â | Â |
 Urban | 1,511 (16.64) | 1,280 (16.18) | 231 (19.69) |
 Rural | 7,571 (83.36) | 6,629 (83.82) | 942 (80.31) |
Tobacco use | Â | Â | Â |
 No | 5,139 (56.58) | 4,674 (59.1) | 465 (39.64) |
 Yes | 3,943 (43.42) | 3,235 (40.9) | 708 (60.36) |
Alcohol use | Â | Â | Â |
 No | 8,195 (90.23) | 7,244 (91.59) | 951 (81.07) |
 Yes | 887 (9.77) | 665 (8.41) | 222 (18.93) |
Hypertension | Â | Â | Â |
 No | 6,741 (74.22) | 6,202 (78.42) | 539 (45.95) |
 Yes | 2,341 (25.78) | 1,707 (21.58) | 634 (54.05) |
Dyslipidemia | Â | Â | Â |
 No | 8,484 (93.42) | 7,514 (95.01) | 970 (82.69) |
 Yes | 598 (6.58) | 395 (4.99) | 203 (17.31) |
Obesity | Â | Â | Â |
 No | 8,338 (91.81) | 7,349 (92.92) | 989 (84.31) |
 Yes | 744 (8.19) | 560 (7.08) | 184 (15.69) |
Diabetes mellitus | Â | Â | Â |
 No | 8,356 (92.01) | 7,419 (93.8) | 937 (79.88) |
 Yes | 726 (7.99) | 490 (6.2) | 236 (20.12) |
Chronic kidney disease | Â | Â | Â |
 No | 8,435 (92.88) | 7,502 (94.85) | 933 (79.54) |
 Yes | 647 (7.12) | 407 (5.15) | 240 (20.46) |
Family history of CVD | Â | Â | Â |
 No | 8,823 (97.15) | 7,697 (97.32) | 1,126 (95.99) |
 Yes | 259 (2.85) | 212 (2.68) | 47 (4.01) |
HIV transmission risk | Â | Â | Â |
 Heterosexual | 1,632 (17.97) | 1,311 (16.58) | 321 (27.37) |
 MSM | 4,868 (53.6) | 4,467 (56.48) | 401 (34.19) |
 Injecting Drug Use | 473 (5.21) | 380 (4.8) | 93 (7.93) |
 Other | 2,109 (23.22) | 1,751 (22.14) | 358 (30.52) |
First cd4 counts (cells/mm3) | Â | Â | Â |
 < 200 | 2,606 (28.69) | 2,098 (26.53) | 508 (43.31) |
 200–350 | 1,917 (21.11) | 1,705 (21.56) | 212 (18.07) |
 > 350 | 4,559 (50.2) | 4,106 (51.92) | 453 (38.62) |
Recent cd4 counts (cells/mm3) | Â | Â | Â |
 < 200 | 1,207 (13.29) | 776 (9.81) | 431 (36.74) |
 200–350 | 1,102 (12.13) | 932 (11.78) | 170 (14.49) |
 > 350 | 6,773 (74.58) | 6,201 (78.4) | 572 (48.76) |
% of days with low cd4 counts | Â | Â | Â |
 0–25% | 3,767 (41.48) | 3,485 (44.06) | 282 (24.04) |
 26-70% | 2,964 (32.64) | 2,537 (32.08) | 427 (36.4) |
 71-100% | 2,351 (25.89) | 1,887 (23.86) | 464 (39.56) |
% of days with viral suppression | Â | Â | Â |
 0–20% | 2,915 (32.1) | 2,243 (28.36) | 672 (57.29) |
 21-50% | 2,168 (23.87) | 1,952 (24.68) | 216 (18.41) |
 51-100% | 3,999 (44.03) | 3,714 (46.96) | 285 (24.3) |
AIDS at HIV diagnosis | Â | Â | Â |
 No | 7,172 (78.97) | 6,375 (80.6) | 797 (67.95) |
 Yes | 1,910 (21.03) | 1,534 (19.4) | 376 (32.05) |
% of years in retention in care | Â | Â | Â |
 0–30% | 1,993 (21.94) | 1,641 (20.75) | 352 (30.01) |
 31-75% | 2,656 (29.24) | 2,428 (30.7) | 228 (19.44) |
 76-100% | 4,433 (48.81) | 3,840 (48.55) | 593 (50.55) |
Timely linkage to care | Â | Â | Â |
 No | 3,443 (37.91) | 3,018 (38.16) | 425 (36.23) |
 Yes | 5,639 (62.09) | 4,891 (61.84) | 748 (63.77) |